nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Topotecan—ovarian cancer	0.0185	0.354	CbGbCtD
Alfuzosin—CYP3A4—Vinorelbine—ovarian cancer	0.013	0.25	CbGbCtD
Alfuzosin—CYP3A4—Paclitaxel—ovarian cancer	0.00916	0.175	CbGbCtD
Alfuzosin—CYP3A4—Docetaxel—ovarian cancer	0.00663	0.127	CbGbCtD
Alfuzosin—Terazosin—ABCB1—ovarian cancer	0.00627	0.412	CrCbGaD
Alfuzosin—CYP3A4—Doxorubicin—ovarian cancer	0.00494	0.0945	CbGbCtD
Alfuzosin—Doxazosin—ABCB1—ovarian cancer	0.00466	0.306	CrCbGaD
Alfuzosin—Prazosin—ABCB1—ovarian cancer	0.00429	0.282	CrCbGaD
Alfuzosin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00189	0.00202	CcSEcCtD
Alfuzosin—Pruritus—Melphalan—ovarian cancer	0.00187	0.002	CcSEcCtD
Alfuzosin—Rhinitis—Docetaxel—ovarian cancer	0.00186	0.00199	CcSEcCtD
Alfuzosin—Diarrhoea—Topotecan—ovarian cancer	0.00185	0.00198	CcSEcCtD
Alfuzosin—Back pain—Paclitaxel—ovarian cancer	0.00184	0.00197	CcSEcCtD
Alfuzosin—Pharyngitis—Docetaxel—ovarian cancer	0.00184	0.00197	CcSEcCtD
Alfuzosin—Urticaria—Vinorelbine—ovarian cancer	0.00183	0.00197	CcSEcCtD
Alfuzosin—Urinary tract disorder—Docetaxel—ovarian cancer	0.00183	0.00196	CcSEcCtD
Alfuzosin—Abdominal pain—Vinorelbine—ovarian cancer	0.00182	0.00196	CcSEcCtD
Alfuzosin—Connective tissue disorder—Docetaxel—ovarian cancer	0.00182	0.00195	CcSEcCtD
Alfuzosin—Urethral disorder—Docetaxel—ovarian cancer	0.00182	0.00195	CcSEcCtD
Alfuzosin—Diarrhoea—Melphalan—ovarian cancer	0.00181	0.00194	CcSEcCtD
Alfuzosin—Osteoarthritis—Epirubicin—ovarian cancer	0.00181	0.00194	CcSEcCtD
Alfuzosin—Nausea—Chlorambucil—ovarian cancer	0.0018	0.00193	CcSEcCtD
Alfuzosin—Dizziness—Topotecan—ovarian cancer	0.00178	0.00191	CcSEcCtD
Alfuzosin—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00177	0.00189	CcSEcCtD
Alfuzosin—Angioedema—Paclitaxel—ovarian cancer	0.00174	0.00186	CcSEcCtD
Alfuzosin—Eye disorder—Docetaxel—ovarian cancer	0.00173	0.00186	CcSEcCtD
Alfuzosin—Flushing—Docetaxel—ovarian cancer	0.00172	0.00184	CcSEcCtD
Alfuzosin—Cardiac disorder—Docetaxel—ovarian cancer	0.00172	0.00184	CcSEcCtD
Alfuzosin—Vomiting—Topotecan—ovarian cancer	0.00172	0.00184	CcSEcCtD
Alfuzosin—Malaise—Paclitaxel—ovarian cancer	0.00172	0.00184	CcSEcCtD
Alfuzosin—Vertigo—Paclitaxel—ovarian cancer	0.00171	0.00183	CcSEcCtD
Alfuzosin—Syncope—Paclitaxel—ovarian cancer	0.00171	0.00183	CcSEcCtD
Alfuzosin—Rash—Topotecan—ovarian cancer	0.0017	0.00182	CcSEcCtD
Alfuzosin—Dermatitis—Topotecan—ovarian cancer	0.0017	0.00182	CcSEcCtD
Alfuzosin—Headache—Topotecan—ovarian cancer	0.00169	0.00181	CcSEcCtD
Alfuzosin—Palpitations—Paclitaxel—ovarian cancer	0.00168	0.0018	CcSEcCtD
Alfuzosin—Angiopathy—Docetaxel—ovarian cancer	0.00168	0.0018	CcSEcCtD
Alfuzosin—Vomiting—Melphalan—ovarian cancer	0.00168	0.0018	CcSEcCtD
Alfuzosin—Loss of consciousness—Paclitaxel—ovarian cancer	0.00167	0.00179	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—ovarian cancer	0.00167	0.00179	CcSEcCtD
Alfuzosin—Mediastinal disorder—Docetaxel—ovarian cancer	0.00167	0.00179	CcSEcCtD
Alfuzosin—Rash—Melphalan—ovarian cancer	0.00167	0.00179	CcSEcCtD
Alfuzosin—Dermatitis—Melphalan—ovarian cancer	0.00166	0.00179	CcSEcCtD
Alfuzosin—Asthenia—Vinorelbine—ovarian cancer	0.00166	0.00178	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00165	0.00177	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—ovarian cancer	0.00165	0.00177	CcSEcCtD
Alfuzosin—Pruritus—Vinorelbine—ovarian cancer	0.00163	0.00175	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—ovarian cancer	0.00163	0.00175	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00163	0.00174	CcSEcCtD
Alfuzosin—Mental disorder—Docetaxel—ovarian cancer	0.00162	0.00174	CcSEcCtD
Alfuzosin—Arthralgia—Paclitaxel—ovarian cancer	0.00162	0.00174	CcSEcCtD
Alfuzosin—Chest pain—Paclitaxel—ovarian cancer	0.00162	0.00174	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00161	0.00173	CcSEcCtD
Alfuzosin—Nausea—Topotecan—ovarian cancer	0.0016	0.00172	CcSEcCtD
Alfuzosin—Discomfort—Paclitaxel—ovarian cancer	0.0016	0.00172	CcSEcCtD
Alfuzosin—Dry mouth—Paclitaxel—ovarian cancer	0.00158	0.0017	CcSEcCtD
Alfuzosin—Diarrhoea—Vinorelbine—ovarian cancer	0.00158	0.00169	CcSEcCtD
Alfuzosin—Nausea—Melphalan—ovarian cancer	0.00157	0.00168	CcSEcCtD
Alfuzosin—Back pain—Docetaxel—ovarian cancer	0.00156	0.00167	CcSEcCtD
Alfuzosin—Oedema—Paclitaxel—ovarian cancer	0.00155	0.00167	CcSEcCtD
Alfuzosin—Infection—Paclitaxel—ovarian cancer	0.00154	0.00165	CcSEcCtD
Alfuzosin—Shock—Paclitaxel—ovarian cancer	0.00153	0.00164	CcSEcCtD
Alfuzosin—Dizziness—Vinorelbine—ovarian cancer	0.00153	0.00164	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00153	0.00164	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00153	0.00164	CcSEcCtD
Alfuzosin—Nervous system disorder—Paclitaxel—ovarian cancer	0.00152	0.00163	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—ovarian cancer	0.00152	0.00163	CcSEcCtD
Alfuzosin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00152	0.00163	CcSEcCtD
Alfuzosin—Tachycardia—Paclitaxel—ovarian cancer	0.00152	0.00163	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—ovarian cancer	0.00151	0.00162	CcSEcCtD
Alfuzosin—Skin disorder—Paclitaxel—ovarian cancer	0.00151	0.00162	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.0015	0.00161	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—ovarian cancer	0.0015	0.00161	CcSEcCtD
Alfuzosin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.0015	0.00161	CcSEcCtD
Alfuzosin—Vomiting—Vinorelbine—ovarian cancer	0.00147	0.00157	CcSEcCtD
Alfuzosin—Rash—Vinorelbine—ovarian cancer	0.00146	0.00156	CcSEcCtD
Alfuzosin—Dermatitis—Vinorelbine—ovarian cancer	0.00145	0.00156	CcSEcCtD
Alfuzosin—Hypotension—Paclitaxel—ovarian cancer	0.00145	0.00156	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00145	0.00156	CcSEcCtD
Alfuzosin—Headache—Vinorelbine—ovarian cancer	0.00145	0.00155	CcSEcCtD
Alfuzosin—Syncope—Docetaxel—ovarian cancer	0.00145	0.00155	CcSEcCtD
Alfuzosin—Palpitations—Docetaxel—ovarian cancer	0.00143	0.00153	CcSEcCtD
Alfuzosin—Loss of consciousness—Docetaxel—ovarian cancer	0.00142	0.00152	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00141	0.00152	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—ovarian cancer	0.00141	0.00151	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—ovarian cancer	0.00139	0.00149	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—ovarian cancer	0.00139	0.00149	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—ovarian cancer	0.00139	0.00149	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—ovarian cancer	0.00139	0.00149	CcSEcCtD
Alfuzosin—Somnolence—Paclitaxel—ovarian cancer	0.00138	0.00148	CcSEcCtD
Alfuzosin—Arthralgia—Docetaxel—ovarian cancer	0.00137	0.00147	CcSEcCtD
Alfuzosin—Chest pain—Docetaxel—ovarian cancer	0.00137	0.00147	CcSEcCtD
Alfuzosin—Nausea—Vinorelbine—ovarian cancer	0.00137	0.00147	CcSEcCtD
Alfuzosin—Dyspepsia—Paclitaxel—ovarian cancer	0.00137	0.00147	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00136	0.00146	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00136	0.00146	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—ovarian cancer	0.00136	0.00145	CcSEcCtD
Alfuzosin—Dry mouth—Docetaxel—ovarian cancer	0.00134	0.00144	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.00134	0.00144	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00134	0.00144	CcSEcCtD
Alfuzosin—Fatigue—Paclitaxel—ovarian cancer	0.00134	0.00144	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—ovarian cancer	0.00133	0.00143	CcSEcCtD
Alfuzosin—Pain—Paclitaxel—ovarian cancer	0.00133	0.00142	CcSEcCtD
Alfuzosin—Constipation—Paclitaxel—ovarian cancer	0.00133	0.00142	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00132	0.00141	CcSEcCtD
Alfuzosin—Oedema—Docetaxel—ovarian cancer	0.00132	0.00141	CcSEcCtD
Alfuzosin—Infection—Docetaxel—ovarian cancer	0.00131	0.0014	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—ovarian cancer	0.00131	0.0014	CcSEcCtD
Alfuzosin—Shock—Docetaxel—ovarian cancer	0.00129	0.00139	CcSEcCtD
Alfuzosin—Nervous system disorder—Docetaxel—ovarian cancer	0.00129	0.00138	CcSEcCtD
Alfuzosin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00129	0.00138	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—ovarian cancer	0.00129	0.00138	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—ovarian cancer	0.00129	0.00138	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—ovarian cancer	0.00129	0.00138	CcSEcCtD
Alfuzosin—Tachycardia—Docetaxel—ovarian cancer	0.00128	0.00138	CcSEcCtD
Alfuzosin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00128	0.00137	CcSEcCtD
Alfuzosin—Skin disorder—Docetaxel—ovarian cancer	0.00128	0.00137	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00127	0.00136	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.00126	0.00135	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—ovarian cancer	0.00126	0.00135	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—ovarian cancer	0.00125	0.00134	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—ovarian cancer	0.00124	0.00133	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—ovarian cancer	0.00123	0.00132	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—ovarian cancer	0.00123	0.00132	CcSEcCtD
Alfuzosin—Urticaria—Paclitaxel—ovarian cancer	0.00123	0.00132	CcSEcCtD
Alfuzosin—Hypotension—Docetaxel—ovarian cancer	0.00123	0.00132	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—ovarian cancer	0.00123	0.00132	CcSEcCtD
Alfuzosin—Abdominal pain—Paclitaxel—ovarian cancer	0.00123	0.00132	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—ovarian cancer	0.00122	0.00131	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00122	0.00131	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—ovarian cancer	0.00121	0.0013	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.0012	0.00129	CcSEcCtD
Alfuzosin—Somnolence—Docetaxel—ovarian cancer	0.00117	0.00125	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—ovarian cancer	0.00117	0.00125	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—ovarian cancer	0.00116	0.00124	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—ovarian cancer	0.00116	0.00124	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—ovarian cancer	0.00116	0.00124	CcSEcCtD
Alfuzosin—Dyspepsia—Docetaxel—ovarian cancer	0.00116	0.00124	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—ovarian cancer	0.00115	0.00123	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00114	0.00122	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00114	0.00122	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00114	0.00122	CcSEcCtD
Alfuzosin—Fatigue—Docetaxel—ovarian cancer	0.00113	0.00122	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—ovarian cancer	0.00113	0.00122	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—ovarian cancer	0.00113	0.00122	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—ovarian cancer	0.00113	0.00121	CcSEcCtD
Alfuzosin—Pain—Docetaxel—ovarian cancer	0.00113	0.00121	CcSEcCtD
Alfuzosin—Constipation—Docetaxel—ovarian cancer	0.00113	0.00121	CcSEcCtD
Alfuzosin—Asthenia—Paclitaxel—ovarian cancer	0.00111	0.00119	CcSEcCtD
Alfuzosin—Pruritus—Paclitaxel—ovarian cancer	0.0011	0.00118	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—ovarian cancer	0.00109	0.00117	CcSEcCtD
Alfuzosin—Feeling abnormal—Docetaxel—ovarian cancer	0.00108	0.00116	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—ovarian cancer	0.00108	0.00116	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00108	0.00115	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—ovarian cancer	0.00107	0.00115	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—ovarian cancer	0.00107	0.00115	CcSEcCtD
Alfuzosin—Diarrhoea—Paclitaxel—ovarian cancer	0.00106	0.00114	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—ovarian cancer	0.00105	0.00113	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—ovarian cancer	0.00105	0.00112	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00104	0.00112	CcSEcCtD
Alfuzosin—Abdominal pain—Docetaxel—ovarian cancer	0.00104	0.00112	CcSEcCtD
Alfuzosin—Dizziness—Paclitaxel—ovarian cancer	0.00103	0.0011	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—ovarian cancer	0.00101	0.00109	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—ovarian cancer	0.00101	0.00108	CcSEcCtD
Alfuzosin—Vomiting—Paclitaxel—ovarian cancer	0.000987	0.00106	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—ovarian cancer	0.000981	0.00105	CcSEcCtD
Alfuzosin—Rash—Paclitaxel—ovarian cancer	0.000979	0.00105	CcSEcCtD
Alfuzosin—Dermatitis—Paclitaxel—ovarian cancer	0.000978	0.00105	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—ovarian cancer	0.000977	0.00105	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—ovarian cancer	0.000975	0.00105	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—ovarian cancer	0.000974	0.00104	CcSEcCtD
Alfuzosin—Headache—Paclitaxel—ovarian cancer	0.000973	0.00104	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—ovarian cancer	0.000961	0.00103	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—ovarian cancer	0.000956	0.00103	CcSEcCtD
Alfuzosin—Asthenia—Docetaxel—ovarian cancer	0.000944	0.00101	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000934	0.001	CcSEcCtD
Alfuzosin—Pruritus—Docetaxel—ovarian cancer	0.000931	0.000999	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—ovarian cancer	0.000926	0.000993	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—ovarian cancer	0.000926	0.000993	CcSEcCtD
Alfuzosin—Nausea—Paclitaxel—ovarian cancer	0.000922	0.000989	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00092	0.000986	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—ovarian cancer	0.000915	0.000981	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—ovarian cancer	0.000908	0.000973	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—ovarian cancer	0.000906	0.000971	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—ovarian cancer	0.000904	0.00097	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—ovarian cancer	0.000903	0.000968	CcSEcCtD
Alfuzosin—Diarrhoea—Docetaxel—ovarian cancer	0.000901	0.000966	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—ovarian cancer	0.000889	0.000954	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—ovarian cancer	0.000888	0.000952	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000885	0.000949	CcSEcCtD
Alfuzosin—Infection—Epirubicin—ovarian cancer	0.000882	0.000946	CcSEcCtD
Alfuzosin—Shock—Epirubicin—ovarian cancer	0.000873	0.000937	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—ovarian cancer	0.000871	0.000934	CcSEcCtD
Alfuzosin—Dizziness—Docetaxel—ovarian cancer	0.00087	0.000933	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000869	0.000932	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—ovarian cancer	0.000866	0.000929	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—ovarian cancer	0.000862	0.000925	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000858	0.00092	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—ovarian cancer	0.000857	0.000919	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—ovarian cancer	0.000857	0.000919	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000851	0.000913	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—ovarian cancer	0.000847	0.000908	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—ovarian cancer	0.000838	0.000899	CcSEcCtD
Alfuzosin—Vomiting—Docetaxel—ovarian cancer	0.000837	0.000897	CcSEcCtD
Alfuzosin—Rash—Docetaxel—ovarian cancer	0.00083	0.00089	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—ovarian cancer	0.00083	0.00089	CcSEcCtD
Alfuzosin—Dermatitis—Docetaxel—ovarian cancer	0.000829	0.000889	CcSEcCtD
Alfuzosin—Headache—Docetaxel—ovarian cancer	0.000825	0.000884	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—ovarian cancer	0.000821	0.000881	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—ovarian cancer	0.000816	0.000875	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000809	0.000867	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—ovarian cancer	0.000808	0.000867	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000806	0.000864	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000804	0.000862	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—ovarian cancer	0.000802	0.00086	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—ovarian cancer	0.000798	0.000856	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000794	0.000852	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—ovarian cancer	0.000789	0.000846	CcSEcCtD
Alfuzosin—Nausea—Docetaxel—ovarian cancer	0.000782	0.000838	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—ovarian cancer	0.000781	0.000838	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—ovarian cancer	0.000768	0.000823	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000766	0.000822	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—ovarian cancer	0.000765	0.000821	CcSEcCtD
Alfuzosin—Pain—Epirubicin—ovarian cancer	0.000759	0.000814	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—ovarian cancer	0.000759	0.000814	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000748	0.000803	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—ovarian cancer	0.000732	0.000784	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—ovarian cancer	0.00073	0.000783	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000726	0.000778	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—ovarian cancer	0.000723	0.000775	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000709	0.00076	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—ovarian cancer	0.000708	0.000759	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—ovarian cancer	0.000705	0.000756	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—ovarian cancer	0.000702	0.000753	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—ovarian cancer	0.000702	0.000753	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—ovarian cancer	0.000702	0.000753	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000677	0.000726	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000672	0.00072	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—ovarian cancer	0.000653	0.0007	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—ovarian cancer	0.000649	0.000696	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—ovarian cancer	0.000637	0.000683	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—ovarian cancer	0.000628	0.000674	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—ovarian cancer	0.000607	0.000651	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—ovarian cancer	0.000589	0.000632	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—ovarian cancer	0.000587	0.00063	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—ovarian cancer	0.000581	0.000623	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—ovarian cancer	0.000564	0.000605	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—ovarian cancer	0.000562	0.000603	CcSEcCtD
Alfuzosin—Rash—Epirubicin—ovarian cancer	0.00056	0.0006	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—ovarian cancer	0.000559	0.0006	CcSEcCtD
Alfuzosin—Headache—Epirubicin—ovarian cancer	0.000556	0.000596	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—ovarian cancer	0.000543	0.000582	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—ovarian cancer	0.000527	0.000565	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—ovarian cancer	0.000522	0.00056	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—ovarian cancer	0.000518	0.000555	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—ovarian cancer	0.000517	0.000555	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—ovarian cancer	0.000515	0.000552	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—ovarian cancer	0.000488	0.000523	CcSEcCtD
